Castle Biosciences, Inc. · 10 hours ago
IT, Technical Analyst (PIT)
Pittsburgh, PA
Full-time
Onsite
New Grad, Entry LevelCastle Biosciences Inc. is a growing company recognized as a top workplace in the USA. They are seeking an IT, Technical Analyst to serve as the first line of support for users requiring IT assistance and to support IT onboarding activities for new employees.
BiotechnologyHealth CareHealth Diagnostics
No H1B
Responsibilities
This position serves as the first line of support for users requiring IT assistance, completing or escalating help desk requests as needed
The role supports most IT onboarding activities for new employees, including laptop deployments, equipment ordering, and providing basic technical training to ensure a positive onboarding experience
Day-to-day responsibilities vary based on incoming tickets and anticipated new hires
The Technical Analyst spends the majority of time addressing hardware and software issues, assisting users with patience and professionalism, and supporting technical projects such as infrastructure improvements and software changes in collaboration with IT colleagues and cross-functional teams
Qualification
Required
Bachelor's degree in information technology, related field, or related experience in lieu of education
Intermediate understanding of various computer software and hardware
Entry level PowerShell skills with focus on MSFT Active Directory and Office365
Proficient in MFA and SSO setup and troubleshooting
Strong people skills
Benefits
Excellent Annual Salary + 20% Bonus Potential
20 Accrued PTO Days Annually
10 Paid Holidays
401K with 100% Company Match up to 6%
3 Health Care Plan Options + Company HSA Contribution
Company Stock Grant Upon Hire
Company
Castle Biosciences, Inc.
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.
Founded in 2008
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$427.33MKey Investors
BrightEdge FundIndustry VenturesHealthQuest Capital
2020-12-15Post Ipo Equity· $266.8M
2020-06-24Post Ipo Equity· $74M
2019-07-24Series Unknown
Leadership Team
Derek Maetzold
President, CEO and Founder
Recent News
News Powered by Cision
2026-01-22
GlobeNewswire
2026-01-12
Company data provided by crunchbase